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Background. Pyogenic arthritis of the small joints of the hand and wrist is a known but poorly described entity. The objective 
of this work was to characterize the clinical presentation, antimicrobial treatment, and surgical interventions of native small joint 
arthritis (SJA) treated in our tertiary center.
Methods. According to predefined variables, medical records of adult patients with SJA treated in a Swiss university hospital 
between 2005 and 2013 were retrospectively analyzed.
Results. The median age of 97 patients (101 joints) was 52 years (interquartile range [IQR], 38–68 years); 52% had no comorbid-
ity. Small joint arthritis of the second and third fingers accounted for 53% of infections, with metacarpal-phalangeal and proximal 
interphalangeal joints most commonly involved. Of 86 (89%) episodes with an exogenous source, 63 (65%) followed a trauma. 
The most commonly isolated microorganism was Staphylococcus aureus (38%), followed by β-hemolytic streptococci (13%) and 
Pasteurella spp (11%). Eighty-seven episodes (89 joints) in patients with follow-up examinations were included in treatment and 
outcome analyses. Up to 2 surgical interventions were required to cure infection in 74 (83%) joints. Median antimicrobial treatment 
duration was 14 days (IQR, 12–28 days), with amoxicillin/clavulanate administered in 74 (85%) episodes. At follow up, cure of infec-
tion was noted in all episodes and good functional outcome in 79% of episodes.
Conclusions. Small joint arthritis shows considerable differences from clinical patterns reported for larger joints. In our series, 
the outcome was good with no more than 2 surgical interventions and median treatment duration of 14 days in 79% of episodes.
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Pyogenic arthritis of the small joints of the hand and wrist 
is a known but poorly described entity. In previous reports, 
this condition accounted for less than 5% of all joint infec-
tions [1]. In recent analyses of 248 cases of septic arthritis, 37 
(14.9%) involved the hand and 20 (8.1%) involved the wrist 
[2]. The management of pyogenic small joint arthritis (SJA) 
is less standardized than that of septic arthritis of the large 
joints (eg, hip or knee joint) for both surgical treatment and 
antimicrobial therapy. The epidemiology of microorganisms 
causing SJA is not well established, because few studies have 
described it [3–5]. In addition, the optimal duration of anti-
microbial therapy is yet to be elucidated [3, 4]. It is uncertain 
whether smaller and larger joints should be treated equally 
long. The objective of this work was to characterize the 
clinical presentation, the surgical interventions, and antibi-
otic treatment duration of native SJA treated in our tertiary 
center.
METHODS
Subjects, Setting, and Data Set
We reviewed the medical records of adults (ie, age ≥18 years) 
with native SJA treated at the Department of Plastic and Hand 
Surgery, Bern University Hospital, Switzerland, from 2005 to 
2013, according to extensively predefined variables. Two data 
sets were built after data acquisition: one for clinical pres-
entation and one for treatment outcome analyses. For clinical 
presentation analyses, all episodes were reviewed. For outcome 
assessment, only those episodes of infection with a follow-up 
investigation were included.
Definitions
An episode of infection required the clinical suspicion of SJA 
and at least one of the following criteria: (1) intraoperative pus 
surrounding the joint, (2) evidence of leucocytes in micro-
scopic analyses of obtained samples, and (3) growth of micro-
organisms consistent with SJA. The final diagnosis of SJA also 
required exclusion of an alternative diagnosis (eg, gout).
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For all analyses except surgical treatment, the total number of 
infection episodes was defined as the denominator. Thus, each 
patient could have only 1 episode, irrespective of the number of 
joints involved, unless it reoccurred after a previous episode had 
been classified as having been eradicated. The second episode 
was further categorized as relapse (ie, infection with the same 
microorganism) or new infection (ie, infection with a newly cul-
tured microorganism). For analyses of surgical treatment, the 
total number of involved joints was defined as the denominator.
On the basis of the patient’s history, pathogenesis was categorized 
as hematogenous, exogenous, or inconclusive. Each episode was 
categorized as either acute (symptoms for <3 weeks for hematog-
enous or <4 weeks for exogenous pathogenesis) or chronic (symp-
toms for ≥3 weeks for hematogenous or ≥4 weeks for exogenous 
pathogenesis). These definitions were extrapolated from those used 
for the categorization of periprosthetic joint infections [6].
Surgical treatment was classified as a complex or noncom-
plex procedure. The latter consisted of incision, debridement, 
lavage, and drainage with the intention to preserve the joint. 
More extensive surgical procedures were categorized as com-
plex interventions.
For outcome assessment, the latest available follow-up exam-
ination was used. Assessments included cure of infection and 
regain of joint function.
Statistical Analyses
GraphPad Prism 5.0 was used for statistical analysis. Differences 
in group proportions were assessed (1) by contingency tables and 
the χ2 test or (2) by Fisher’s exact probability test if the frequency 
was less than 5. A 2-tailed P value of ≤.05 was considered signifi-
cant. The local ethical committee and the Department of Research 
of the University Hospital of Bern, Switzerland, approved the 
study (Cantonal Ethical Committee Bern: 2016-01756).
RESULTS
Number of Native Small Joint Arthritis Episodes
In the 9-year period included in the study, we identified 137 
episodes. Twenty-seven episodes were excluded because of 
unfulfilled infection criteria (20 episodes), insufficient data (5 
episodes), an alternative diagnosis (1 episode), or patient age 
<18 years (1 episode). Thirteen episodes were infections involv-
ing an implant. Thus, 97 native SJA episodes were available for 
clinical presentation analyses. Each patient had only 1 infection 
episode, and no relapses or second episodes of infection were 
noted. Of these 97 episodes, 101 small joints were involved. Ten 
patients with 10 episodes that involved 12 joints were lost to 
follow up. Thus, 87 SJA episodes of infection involving 89 joints 
were available for outcome analyses.
Clinical Presentation
Demographics
 The median age of patients was 52 years (interquartile range 
[IQR], 38–68  years), and 62% were male. Fifty (52%) of the 
patients had no comorbidities. Of the other 47 (48%) patients, 
comorbidities included chronic heart failure (11%), arterial 
hypertension (9%), renal insufficiency (9%), and diabetes mel-
litus (8%). A rheumatic disorder (Sjögren syndrome, rheuma-
toid arthritis, gout, crystal arthritis [eg, calcium pyrophosphate 
dihydrate crystal deposition disease], connective tissue disease, 
psoriasis, systemic lupus erythematosus) was described in 16 
(16%) patients, and 13 (13%) individuals were taking immuno-
suppressive drugs (eg, prednisolone) or had a comorbidity that 
impaired immunity (eg, chronic lymphatic leukemia).
Involved Small Joints and Postulated Pathogenesis
 In 48 (49%) patients, infections occurred in the right hand, and 
in 49 (51%) patients, infections occurred in the left hand. The 
distribution of the involved joints is illustrated in Figure 1. Small 
joint arthritis of the second and third finger together accounted 
for more than half (n = 53 of 101, 53%) of all involved joints. 
Infections of the metacarpal-phalangeal and proximal inter-
phalangeal joints of these 2 fingers accounted for 40% (n = 40 of 
101) of all involved joints.
Categorization of pathogenesis was possible in all cases. In 
86 (89%) episodes, the postulated pathogenesis was exogenous, 
and in 63 (65%) of these, infection followed trauma. The most 
common traumas were cut, stab, or bruise injuries related to 
job or household activities (45 [46%] of 97 episodes, 71% of 63 
exogenous episodes), followed by animal bites (18 [19%] of 97 
episodes, 29% of 63 exogenous episodes). Of the remaining 23 
episodes belonging to the exogenous group, infection evolved 
from adjacent infected tissue (eg, infected gout tophus perfo-
rated into the joint, untreated skin and soft tissue infection) in 14 
episodes and from a previous medical intervention (iatrogenic) 
14
6
7 1
5
3
7
12
9 7
2
5
4118
Figure 1. Distribution of 101 small joints involved in 97 episodes of pyogenic 
arthritis.
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in 9 episodes. In 11 (11%) episodes with a presumed hematoge-
nous pathogenesis, the source of infection remained undetected 
in most cases (8 of 11 episodes). In these cases, the pathogenesis 
was postulated from the history of a previous sepsis or proven 
bacteremia. Foci for hematogenous seeding were identified in 3 
episodes and included aortic valve infective endocarditis, nee-
dle injection abscess in an intravenous drug user, and urinary 
tract infection. The duration of symptoms before presentation 
was often short. The overall mean duration was 5.4 days, and 82 
(85%) of 97 SJA episodes were categorized as acute infections.
Microbiology
 The list of identified microorganisms is presented in Table 1. 
The most frequent isolated microorganism was Staphylococcus 
aureus (38%), followed by β-hemolytic streptococci (13%) and 
Pasteurella spp (11%). In 7 (7%) episodes, more than 1 patho-
gen was identified (ie, polymicrobial infection), whereas in the 
remaining 61 (63%) episodes, only 1 microorganism was culti-
vated. In 29 (30%) of 97 episodes, no organism was identified, 
but the definition of infection was fulfilled. In retrospect, the 
resistance profiles of the isolated microorganisms indicated that 
empiric therapy with amoxicillin/clavulanate would have been 
active against 84% of 83 different pathogens.
In 56 (58%) of 97 episodes, antimicrobial prophylaxis was 
given before we obtained biopsy samples. The most frequently 
administered compound was amoxicillin/clavulanate (66%). 
The difference of culture-negative SJA with antibiotic prophy-
laxis administered before biopsies samples were obtained (14%) 
and culture-positive SJA in which antibiotic therapy was admin-
istered only after samples were obtained (27%) was statistically 
not significant (χ2 with Yates’ correction, 2-tailed P = .314).
Treatment and Outcome
Only infection episodes with at least 1 follow-up examina-
tion were included in these analyses (87 episodes involving 89 
joints).
Surgical Therapy
 The number of joints (and not the number of episodes) was 
used as the denominator in our analysis of surgical therapy. 
Among noncomplex cases, 63 (71%) of 89 joints required only 
1 intervention, and 11 (12%) required 2 surgical interventions. 
Of these 74 (83%) joints, the first intervention consisted of 
incision, lavage, and debridement, whereas the second inter-
vention was considered a second look. In 3 (3%) additional 
joints, more than 2 interventions were required. The surgical 
procedure in the other 12 (13%) joints was considered com-
plex. In 4 joints, arthrodesis (1 temporary, 3 permanent) was 
performed; in 4 joints, soft tissue damage required a flap; and 
in 4 joints, the extent of infection required amputation (2 on 
the distal interphalangeal and 2 on the proximal interphalan-
geal level).
Agent and Duration of Antimicrobial Chemotherapy
 Amoxicillin/clavulanate was the most frequently adminis-
tered compound in the postoperative period (74 [85%] of 87 
episodes). The compound was given intravenously (IV) with 
a dose ranging from 1.2 to 2.2 grams every 6 to 8 hours. In 60 
(81%) of these 74 episodes, empiric therapy with amoxicillin/
clavulanate was continued after microbiological results were 
available. The oral dose ranged from 625 to 1000  mg every 
8 hours, and the transition from IV to oral route occurred 
3 to 5 days after definite surgery in the vast majority of the 
cases. Other compounds, such as clindamycin (n = 17, 20%) 
and ciprofloxacin (n  =  9, 10%, either monotherapy or in 
combination with another compound), were administered 
less frequently. The overall median treatment duration was 
14 days (IQR, 12–28 days). Of the 72 episodes involving 74 
joints that required only 1 or 2 noncomplex surgical interven-
tions, the median treatment duration was also 14 days (IQR, 
9–19 days).
Follow-up Examination
 The median time interval from the last surgical interven-
tion to the follow-up investigation in our outpatient clinic 
was 2.3  months (IQR, 1–5  months). Infection resolution was 
observed in all episodes. Joint function was impaired or non-
existent in 12 (13%) of 89 joints (see Surgical Therapy section). 
In 7 additional (8%) cases, painful arthrosis developed and 
required arthrodesis. In 1 case, postinfectious extensor tendon 
adhesion occurred and tenolysis was performed. Further follow 
up was uneventful. Thus, infections were cured in 100% of our 
serious native SJA episodes, and joint function was not consid-
erably impaired in 79% of episodes.
Table 1. Microorganisms Cultured From 97 Patients With Small Joint Ar-
thritis of the Hand and Wrist
Microorganisms n (%)a
Staphylococcus aureus 37 (38)
β-hemolytic streptococci 13 (13)
Pasteurella spp 11 (11)
Gram-negative bacillib 7 (7)
Streptococcus pneumoniae 2 (2)
Fungic 2 (2)
Anaerobes 1 (1)
Otherd 3 (3)
Polymicrobial infection 7 (7)
Monomicrobial infection 61 (63)
No growth 29 (30)
aThe sum of percentages of microorganisms is 77% (growth in 71% of infection episodes) 
because of polymicrobial infections.
bGram-negative bacilli consisted of Enterobacter cloacae, Escherichia coli, Pantoea agglom-
erans, Aeromonas hydrophila, and Pseudomonas aeruginosa.
cFungi consisted of Candida albicans and Trichosporon asahii.
dOther consisted of coagulase-negative staphylococci and Corynebacterium pseudotuber-
culosis, microorganisms that were considered clinically relevant by the treating team.
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DISCUSSION
Pyogenic SJA of the hand and wrist requires prompt treat-
ment to avoid articular destruction with consecutive impaired 
function [7]. Therefore, patients with SJA should be rapidly 
transferred to centers in which pyogenic SJA is managed by 
an interdisciplinary team consisting of a hand surgeon and an 
infectious diseases specialist.
In this study, we were able to analyze a larger number of SJA 
episodes than have previously been reported [3, 4, 8–10]. We 
noted 3 considerable differences between septic arthritis of the 
larger joints (eg, hip or knee joint) described in the literature 
and our series of pyogenic SJA.
First, the diagnosis of pyogenic SJA is less standardized than 
the diagnosis of septic arthritis in larger joints. Although local 
pain, warmth, swelling, and decreased range of motion in the 
involved joint are important clinical features for the diagnosis 
of SJA, synovial fluid is not obtained to determine a leucocyte 
count or the proportion of polymorphonuclear leucocytes, 
nor is it obtained to determine glucose or lactate levels. In 
contrast, laboratory analysis of synovial fluid contributes to 
the diagnosis in larger joints [11]. Nonetheless, in SJA, sam-
ples must be obtained for microbiological and crystal analyses 
because simultaneous crystalline and bacterial arthritis can 
occur. Alongside microscopic examination of Gram-stained 
samples, a semiquantitative leucocyte count should be per-
formed, although this method is imprecise. To the best of 
our knowledge, no criteria for the definition of SJA have been 
formulated. In this study, we postulated rigid criteria before 
obtaining data. However, these criteria need to be validated 
in a different patient population (internal validation) and in 
other centers (external validation) before the definition can 
be widely used.
Second, a considerable proportion of patients with septic 
arthritis of larger joints are older than 60 years or have comor-
bidities that are known risk factors for infection [12, 13]. In 
contrast, more than half of our patients had no comorbidity 
and the median age was 52  years. Diabetes mellitus, a rheu-
matic disorder, or immunosuppression were each reported in 
approximately 10% of our population. Thus, patients with SJA 
are commonly younger and healthier than those reported in the 
literature with septic arthritis of the larger joints.
Third, the pathogenesis of most septic arthritis cases of the 
larger joints is hematogenous [14]. The larger volume within 
these joints allow accumulation of a considerable amount of 
cells contributing to inflammation. Laboratory values such 
as white blood cell count or C-reactive protein in the serum 
are helpful in the diagnosis of large joint arthritis. In SJA, the 
majority of infections occur exogenous. The joint volume is 
smaller. Systemic inflammatory parameters in serum are often 
not markedly elevated. In our series, the vast majority of infec-
tions occurred after trauma, such as injuries related to job or 
household activities or animal bites. Of interest and in contrast 
to other reports [15], no fight bite was noted within our cohort.
The types of injury parallel the most frequent patho-
gens. Staphylococcus aureus, β-hemolytic staphylococci, and 
Pasteurella spp accounted for 62% of all isolated microorgan-
isms. Moreover, the observation that 84% of identified microor-
ganisms were susceptible to amoxicillin/clavulanate treatment 
justifies our policy to use this agent as an empiric postoperative 
agent. This may not be true for other centers where the prev-
alence of methicillin-resistant S aureus or multidrug-resistant 
Gram-negative bacilli is higher than in our institution.
A high proportion of patients (58%) received antibiotics 
before surgical intervention. This observation can be explained 
by the fact that most infections were posttraumatic. According 
to Swiss recommendations, animal bites should be treated 
empirically with antibiotics [16]. In addition, in available oper-
ating theaters within a hospital, indications for surgery other 
than hand infections are prioritized in cases of emergency 
[17]. If the waiting time for surgery is significant, patients may 
receive preemptive antibiotic therapy. This practice can alter 
the microbiological results of intraoperatively obtained samples 
[18]. Although we did not find a statistical difference in bac-
terial growth between patients with and without antimicrobial 
prophylaxis, we cannot estimate the role of antimicrobial agents 
in susceptible microorganisms only. In other words, the growth 
of pathogens resistant to antimicrobial prophylaxis may have 
biased the categorical variable.
Incision, lavage, and debridement is very effective in SJA. In 
the vast majority of infection episodes (83%) in our study, only 
1 or 2 interventions were necessary. This result indicates the sur-
gical possibility of thoroughly washing out a small joint, a task 
that can be difficult in larger joints. It also points towards the 
importance of rapid referral of patients to preserve the joint. In 
12 (13%) of 89 joints, the infection was associated with destruc-
tive development, requiring extensive surgery. This proportion 
is comparable to that reported in other series [3, 4].
The optimal antimicrobial treatment duration in SJA is 
undetermined. In larger joints, antibiotics are given for up to 
6 weeks, the first 2 weeks of antibiotics administered intrave-
nously [19]. In our patient population, the decision on treat-
ment duration is taken on the basis of clinical examination by 
the interdisciplinary team. Half of our patients were treated for 
14 days or less, irrespective of the isolated microorganism. In 
noncomplex cases, 75% of patients had a treatment duration of 
19 days or less. In our institution, the switch from intravenous 
to oral treatment is commonly performed no later than the fifth 
day after surgery in these cases. Because our study design did 
not include a comparison group, we cannot firmly conclude 
whether antibiotic treatment duration in SJAs can be shortened. 
Nonetheless, we experienced high cure rates with short treat-
ment duration in this study.
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Our study has limitations, including its retrospective nature 
and the use of medical records for data collection. However, 
all variables and definitions were determined before obtain-
ing data. The definition of infection also requires validation. 
Categorization of acute and chronic infection was arbitrary. 
It was transferred from categorization of periprosthetic joint 
infection because no uniformly accepted categorization for 
SJA is available. However, in retrospect, duration of symptoms 
was short in the vast majority of cases, irrespective of catego-
rization. We were unable to analyze the true influence of anti-
microbial prophylaxis on culture negativity, but all infections 
were classified as cured in follow-up examinations. We did not 
compare surgical techniques between various surgeons, and we 
considered the surgical intervention in noncomplex cases to be 
standard procedure. There is no standardized definition of cure. 
Although an amputation cures the infection, it also leads to 
loss of function. In this study, we differentiated between cure of 
infection and regain of joint function, although successful out-
come was only considered when both variables were fulfilled. 
Finally, there was a large variability in time of follow-up exami-
nations among patients, three quarters of them having an exam-
ination within 5 months of surgery. Thus, our outcome results 
may be overestimated. Nonetheless, we expected patients with 
failures to have been referred to our center. As a consequence of 
this study, we have introduced regular and structured follow-up 
examinations per protocol for patients with septic SJA in our 
outpatient clinic.
CONCLUSIONS
In conclusion, our retrospective single-center analyses showed 
that patients with pyogenic SJA are typically younger and 
healthier than those reported with septic arthritis of the larger 
joints. The most common pathogenesis was exogenous inocu-
lation of the joint with S aureus, β-hemolytic streptococci, or 
Pasteurella spp after trauma. Noncomplex cases were success-
fully treated with no more than 2 surgical interventions, and the 
median antimicrobial treatment duration was 14 days.
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